Correlation Between Pharmaceuticals Ultrasector and Ultrashort Latin

Can any of the company-specific risk be diversified away by investing in both Pharmaceuticals Ultrasector and Ultrashort Latin at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pharmaceuticals Ultrasector and Ultrashort Latin into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Pharmaceuticals Ultrasector Profund and Ultrashort Latin America, you can compare the effects of market volatilities on Pharmaceuticals Ultrasector and Ultrashort Latin and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pharmaceuticals Ultrasector with a short position of Ultrashort Latin. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pharmaceuticals Ultrasector and Ultrashort Latin.

Diversification Opportunities for Pharmaceuticals Ultrasector and Ultrashort Latin

-0.83

Correlation Coefficient

Pharmaceuticals Ultrasector  Ultrashort Latin

Pay attention - limited upside

The 3 months correlation between Pharmaceuticals and Ultrashort is -0.83. Overlapping area represents the amount of risk that can be diversified away by holding Pharmaceuticals Ultrasector Pr and Ultrashort Latin America in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ultrashort Latin America and Pharmaceuticals Ultrasector is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pharmaceuticals Ultrasector Profund are associated (or correlated) with Ultrashort Latin. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ultrashort Latin America has no effect on the direction of Pharmaceuticals Ultrasector i.e., Pharmaceuticals Ultrasector and Ultrashort Latin go up and down completely randomly.

Pair Corralation between Pharmaceuticals Ultrasector and Ultrashort Latin

Assuming the 90 days horizon Pharmaceuticals Ultrasector Profund is expected to under-perform the Ultrashort Latin. But the mutual fund apears to be less risky and, when comparing its historical volatility, Pharmaceuticals Ultrasector Profund is 1.53 times less risky than Ultrashort Latin. The mutual fund trades about -0.1 of its potential returns per unit of risk. The Ultrashort Latin America is currently generating about 0.08 of returns per unit of risk over similar time horizon. If you would invest  4,227  in Ultrashort Latin America on October 21, 2024 and sell it today you would earn a total of  488.00  from holding Ultrashort Latin America or generate 11.54% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Pharmaceuticals Ultrasector Pr  vs.  Ultrashort Latin America

Pharmaceuticals Ultrasector

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Pharmaceuticals Ultrasector Profund has generated negative risk-adjusted returns adding no value to fund investors. In spite of latest weak performance, the Fund's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the fund investors.

Ultrashort Latin America

Risk-Adjusted Performance

6 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Ultrashort Latin America are ranked lower than 6 (%) of all funds and portfolios of funds over the last 90 days. In spite of fairly weak forward indicators, Ultrashort Latin showed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Pharmaceuticals Ultrasector and Ultrashort Latin

The main advantage of trading using opposite Pharmaceuticals Ultrasector and Ultrashort Latin positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pharmaceuticals Ultrasector position performs unexpectedly, Ultrashort Latin can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ultrashort Latin will offset losses from the drop in Ultrashort Latin's long position.

The idea behind Pharmaceuticals Ultrasector Profund and Ultrashort Latin America pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.